ATH 0.00% 0.3¢ alterity therapeutics limited

Ann: US patent for next generation neurodegenerative diseases, page-7

  1. 2,810 Posts.
    lightbulb Created with Sketch. 975
    Only some hundred million people have these neurodegenerative diseases today and more will get these every day. A huge need to get phase 2 done for MSA and then more and more of them in other indications. We are dealing not only with brain diseases but also with degeneration of all organs with nerves including heart, muscle, bone, intestine, lungs, skin, etc. Organs do not work without nervation.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $2.733K 832.4K

Buyers (Bids)

No. Vol. Price($)
32 45274833 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126718541 16
View Market Depth
Last trade - 15.57pm 09/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.